Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
7.74
+0.04 (0.52%)
At close: Nov 26, 2025, 4:00 PM EST
7.59
-0.15 (-1.94%)
After-hours: Nov 26, 2025, 6:14 PM EST
Exagen Market Cap
Exagen has a market cap or net worth of $175.41 million as of November 26, 2025. Its market cap has increased by 239.70% in one year.
Market Cap
175.41M
Enterprise Value
167.93M
1-Year Change
239.70%
Ranking
Category
Stock Price
$7.74
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $175.41M, an increase of 177.97%. That is a compound annual growth rate of 17.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 175.41M | 142.57% |
| Dec 31, 2024 | 72.31M | 113.18% |
| Dec 29, 2023 | 33.92M | -13.39% |
| Dec 30, 2022 | 39.17M | -79.17% |
| Dec 31, 2021 | 187.99M | 12.56% |
| Dec 31, 2020 | 167.01M | -47.65% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 19, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 977.96B |
| Johnson & Johnson | 498.72B |
| AbbVie | 409.75B |
| UnitedHealth Group | 294.28B |
| AstraZeneca | 283.06B |
| Merck & Co. | 257.29B |
| Novartis AG | 244.50B |
| Thermo Fisher Scientific | 224.41B |